IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,680,455 | -74.2% | 434,500 | -69.0% | 0.04% | -73.0% |
| Q4 2020 | $64,705,000 | +40.9% | 1,400,851 | +7.3% | 0.14% | +22.6% |
| Q3 2020 | $45,923,000 | -20.3% | 1,305,000 | -44.8% | 0.12% | -22.3% |
| Q2 2020 | $57,614,000 | +262.9% | 2,366,062 | +132.0% | 0.15% | +214.9% |
| Q1 2020 | $15,876,000 | -1.9% | 1,020,000 | 0.0% | 0.05% | +17.5% |
| Q4 2019 | $16,187,000 | – | 1,020,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |